ASPG and pancreatic adenocarcinoma: A follow-on Phase IIb study evaluating erythrocyte-encapsulated asparaginase (relabeled as eryaspase) in combination with chemotherapy in second-line advanced pancreatic adenocarcinoma was conducted.